A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors
Phase 1/2 Recruiting
141 enrolled
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
Phase 1/2 Recruiting
223 enrolled
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
170 enrolled
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Phase 1/2 Recruiting
197 enrolled
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
660 enrolled
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Phase 1/2 Recruiting
126 enrolled
A Study of MHB009C in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
200 enrolled
COMBINE-EGFR-1
Phase 1/2 Recruiting
933 enrolled
BiPAVE-001
Phase 1/2 Recruiting
387 enrolled
A Study of ZL-1310 in Participants With Selected Solid Tumors
Phase 1/2 Recruiting
112 enrolled
A Study of MHB042C in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
200 enrolled
A Study of MHB048C in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
200 enrolled
RAINFOL-01
Phase 1/2 Recruiting
764 enrolled
A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
Phase 1/2 Recruiting
149 enrolled
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Phase 1/2 Recruiting
225 enrolled
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
Phase 1/2 Recruiting
42 enrolled
DUAL-MESO-NK
Phase 1/2 Recruiting
36 enrolled
A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects
Phase 1/2 Recruiting
282 enrolled
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Phase 1/2 Recruiting
434 enrolled
A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
210 enrolled
SENTRY-HER2
Phase 1/2 Recruiting
27 enrolled
Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
Phase 1/2 Recruiting
533 enrolled
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours
Phase 1/2 Recruiting
85 enrolled
COAST
Phase 1/2 Recruiting
76 enrolled
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors
Phase 1/2 Recruiting
120 enrolled
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
Phase 1/2 Recruiting
360 enrolled
A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors
Phase 1/2 Recruiting
86 enrolled
HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor
Phase 1/2 Recruiting
186 enrolled
PARTHENON
Phase 1/2 Recruiting
180 enrolled
ATTEST
Phase 1/2 Recruiting
72 enrolled
Study in Advanced Solid Tumor Patients
Phase 1/2 Recruiting
306 enrolled
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
315 enrolled
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
156 enrolled
A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
146 enrolled
A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors
Phase 1/2 Recruiting
70 enrolled
aCCeleR8-001
Phase 1/2 Recruiting
282 enrolled
Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
87 enrolled
SNV4818 in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
320 enrolled
A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors
Phase 1/2 Recruiting
280 enrolled
LuMIERE
Phase 1/2 Recruiting
222 enrolled
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Phase 1/2 Recruiting
500 enrolled
A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )
Phase 1/2 Recruiting
401 enrolled
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
Phase 1/2 Recruiting
33 enrolled
DOMISOL
Phase 1/2 Recruiting
125 enrolled
A Phase I/â…¡ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
261 enrolled
PRIMROSE
Phase 1/2 Recruiting
234 enrolled
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
202 enrolled
Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
Phase 1/2 Recruiting
220 enrolled
Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer
Phase 1/2 Recruiting
255 enrolled
MARGARET
Phase 1/2 Recruiting
244 enrolled